What is the difference between endogenous GLP-1 and GLP-1 receptor agonists
McDougle, M., de Araujo, A., Singh, A., Yang, M., Braga, I., Paille, V., Mendez-Hernandez, R., Vergara, M., Woodie, L
Investigators have proposed this body-composition profile is consistent with the glucagon-receptor arm contributing energy-expenditure effects beyond simple appetite suppression
The phase 2 trial measured outcomes at 24 and 48 weeks for a reason
GLP-1 also regulates the growth of the Islets of Langerhans and enhances beta cell proliferation and it supports the health of the cells so they have an improved, longer and healthier life span
Despite decades of research and medical advancements, significant challenges remain